从“脾为之卫”探讨延缓胰腺癌演进的治脾调卫机理与策略

张传龙; 李奕; 姜晓晨; 庞博; 花宝金

doi:10.3969/j.issn.1006-2157.2023.03.007

您当前的位置：

首页 >

文章列表页 >

从“脾为之卫”探讨延缓胰腺癌演进的治脾调卫机理与策略

理论研究 | 更新时间：2023-04-07

- 从“脾为之卫”探讨延缓胰腺癌演进的治脾调卫机理与策略
- Exploration of mechanism and strategy to treat spleen disease and adjust defensive qi for delaying the progression of pancreatic cancer based on "spleen acting as the guard for the five zang viscera and six fu viscera"
- 北京中医药大学学报 2023年46卷第3期页码：326-330
- 作者机构：
  
  1.中国中医科学院广安门医院　北京　100053
  2.中国中医科学院广安门医院国际医疗部
- 作者简介：
  
  张传龙，女，在读博士生
  #庞博，男，博士，主任医师，博士生导师，主要研究方向：中医药防治肿瘤及名老中医学术经验传承方法学研究，E-mail: drpangbo@gmail.com
- 基金信息：
  
  中国中医科学院科技创新工程项目(CI2021A01805;CI2021B009);北京市科学技术委员会首都临床诊疗技术研究及示范应用专项(Z191100006619022)
- DOI：10.3969/j.issn.1006-2157.2023.03.007
  中图分类号： R273.59
- 纸质出版日期：2023-03-30，
  
  网络出版日期：2023-01-05，
  
  收稿日期：2022-06-04，
- 稿件说明：
移动端阅览
张传龙, 李奕, 姜晓晨, 等. 从“脾为之卫”探讨延缓胰腺癌演进的治脾调卫机理与策略[J]. 北京中医药大学学报, 2023,46(3):326-330.

ZHANG Chuanlong, LI Yi, JIANG Xiaochen, et al. Exploration of mechanism and strategy to treat spleen disease and adjust defensive qi for delaying the progression of pancreatic cancer based on "spleen acting as the guard for the five zang viscera and six fu viscera"[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(3):326-330.
张传龙, 李奕, 姜晓晨, 等. 从“脾为之卫”探讨延缓胰腺癌演进的治脾调卫机理与策略[J]. 北京中医药大学学报, 2023,46(3):326-330. DOI： 10.3969/j.issn.1006-2157.2023.03.007.

ZHANG Chuanlong, LI Yi, JIANG Xiaochen, et al. Exploration of mechanism and strategy to treat spleen disease and adjust defensive qi for delaying the progression of pancreatic cancer based on "spleen acting as the guard for the five zang viscera and six fu viscera"[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(3):326-330. DOI： 10.3969/j.issn.1006-2157.2023.03.007.

摘要

胰腺疾病多责于脾，中医从脾论治胰腺癌可有效延缓其演变进程，但缺少理论支持，值得进一步探讨。基于对“脾为之卫”内涵的阐发，认为“脾为之卫”是机体护卫功能的高度概括，其正常功能的发挥依赖于“脾主运化”。胰腺癌患者分泌功能异常，胆汁、胰液排出受阻而造成“脾失运化”，导致“脾为之卫”向“脾失之卫”的病理转变，或为胰腺癌演进的核心环节。“脾伤卫弱→脾损卫伐→脾衰卫溃”这一病理演变进程与现代研究中胰腺癌的演变进程高度契合，合理解释了治脾以延缓胰腺癌演进效果显著的机理所在，维护和恢复“脾为之卫”的功能，以重塑胰腺癌肿瘤微环境，是延缓胰腺癌演进的关键。结合现代研究，总结出清脾以复卫气、健脾以行卫气、补脾以生卫气三大治脾调卫策略，以期为临床辨治胰腺癌提供有益参考。

Abstract

Pancreatic diseases are mostly caused by disorders of the spleen. Treatment of pancreatic cancer caused by the spleen based on traditional Chinese medicine can effectively delay its evolution

but there is a lack of theoretical support

which is worthy of further discussion. Based on the elucidation of the connotation of "spleen acting as the guard for the five zang viscera and six fu viscera"

this paper states that "spleen acting as the guard for the five zang viscera and six fu viscera" is a summary of the body’s security function

which depends on "spleen dominant digestion" . The secretory functions of pancreatic cancer patients are abnormal

so the obstruction of bile and pancreatic juice excretion leads to "spleen failing to digest"

which leads to the pathological transformation from "spleen acting as the guard for the five zang viscera and six fu viscera" to "spleen lossing of guard"

or it may be the main cause of the evolution of pancreatic cancer. The pathological evolution process of "spleen injury-spleen failure-spleen collapse" is highly consistent with the evolution of pancreatic cancer based on modern research

which reasonably explains the significant curative effect of spleen treatment on the delay of the progression of pancreatic cancer. It is pointed out that the key to delaying the progression of pancreatic cancer is to maintain and restore the function of the "spleen acting as the guard for the five zang viscera and six fu viscera" in order to reshape the tumor microenvironment of pancreatic cancer. Combined with modern research

this paper summarizes the three spleen-regulating strategies of clearing spleen to restore defensive qi

invigorating spleen to run defensive qi

and tonifying spleen to replenish defensive qi

in order to provide a useful reference for clinical diagnosis and treatment of pancreatic cancer.

关键词

胰腺癌脾为之卫运化分泌功能治脾卫气

Keywords

pancreatic cancerspleen acting as the guard for the five zang-organs and six fu-organsdigestionexocrine functiontreating spleendefensive qi

references

ZHENG RS，ZHANG SW，ZENG HM，et al.Cancer incidence and mortality in China，2016[J].JNCC，2022，2(1)：1－9.

高宇，马云飞，陈宇晗，等．胰腺癌肿瘤微环境的中医药治疗进展[J].中华中医药杂志，2021，36(8)：4799－4801.

肖雅瑜．固脾消积方联合化疗治疗晚期胰腺癌的临床研究[D].长沙：湖南中医药大学，2021.

PORTA M，FABREGAT X，MALATS N，et al.Exocrine pancreatic cancer：symptoms at presentation and their relation to tumour site and stage[J].Clin Transl Oncol，2005，7(5)：189－197.

张玉书．康熙字典[M].上海：汉语大词典出版社，2002：158.

张志聪．黄帝内经灵枢集注[M].孙国中，校注．北京：学苑出版社，2006：291.

黄元御．灵枢悬解[M].孙国中，校注．北京：学苑出版社，2008：258.

刘杰民，黄贵华，纪云西，等．“脾为之卫”的理论内涵与免疫学外延探讨[J].新中医，2011，43(5)：3－5.

张介宾．类经[M].北京：人民卫生出版社，1982：94.

孙建慧，杨倩，张纨，等．脾虚浊毒论[J].北京中医药大学学报，2021，44(9)：812－817.

潘芳，姜晓晨，刘福栋，等．胰腺藏象刍议[J].北京中医药，2020，39(8)：782－784.

王帅，郭允，刘文科，等．胰与中医之脾、散膏的关系探讨[J].中医杂志，2012，53(4)：276－278.

郑树森．胰腺移植[M].北京：人民卫生出版社，2002：17－20.

钱秀云，柳辰玥，刘玥芸，等．《黄帝内经》脾曰备化理论探微[J].时珍国医国药，2022，33(2)：434－436.

王安．基于“脾为之卫”探讨益气解毒方对急性放射损伤小鼠的防护研究[D].北京：北京中医药大学，2020.

刘鲁明．中西医结合治疗胰腺癌的机遇与挑战[J].中国中西医结合杂志，2019，39(1)：18－20.

WANG FJ，WANG P，CHEN LY，et al.TAM Infiltration Differences in “Tumor-First” and “ZHENG-First” Models and the Underlying Inflammatory Molecular Mechanism in Pancreatic Cancer[J].Integr Cancer Ther，2018，17(3)：707－716.

李晶，赵良辰，唐幸林子，等．中医“卫气”与现代免疫调节及肿瘤发生的关系[J].中医肿瘤学杂志，2019，1(2)：18－22.

陈舲，许秋琳，韩慧，等．肿瘤缺氧微环境的中医属性及治则探讨[J].中华中医药杂志，2020，35(12)：6198－6201.

TAO JX，YANG G，ZHOU WC，et al.Targeting hypoxic tumor microenvironment in pancreatic cancer[J].J Hematol Oncol，2021，14(1)：14.

秦越人．难经集注[M].吕广，校注．北京：人民卫生出版社，1963：50－51.

KHAN A，VEGE SS，DUDEJA V，et al.Staging exocrine pancreatic dysfunction[J]. Pancreatology，2022，22(1)：168－172.

李梴．医学入门[M].北京：中国中医药出版社，1995：374.

王桂彬，姜晓晨，刘福栋，等．疮疡理论在肿瘤治疗中的应用探讨[J].中医杂志，2021，62(15)：1294－1298.

CHEN Z，WANG P．Clinical Distribution and Molecular Basis of Traditional Chinese Medicine ZHENG in Cancer[J/OL].Evid Based Complement Alternat Med, 2012: 783923[2022-03-01].https：//www.hindawi.con/journals/ecam/2012/783923/https：//www.hindawi.con/journals/ecam/2012/783923/.

陈联誉．微环境中肿瘤相关成纤维细胞介导的清热化湿中药抗胰腺癌作用研究[D].上海：复旦大学，2013.

QIN C，YANG G，YANG JS，et al.Metabolism of pancreatic cancer：paving the way to better anticancer strategies[M].Mol Cancer，2020，19(1)：50.

王志刚，田劭丹，李加葵，等．健脾祛湿法在胰腺癌辨治中的应用[J].现代中医临床，2022，29(2)：56－59.

汪昂．本草备要[M].北京：人民卫生出版社，1965：13.

汤钊猷．“控癌战”而非“抗癌战”[J].世界科学，2018(2)：32－34.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

卫气虚证诊断规范的构建思路与方法

319例胰腺癌中医证候分布规律及影响因素分析

三焦与四街